Cannara Biotech Inc. (LOVE : TSX)
Common Stock
$1.91
CAD
+0.01 (0.53%)
Last updated: 2026-08-05
Get LOVE alerts:
LOVE
Cannara Biotech Inc.
Performance
1 Day
+0.53%
1 Week
+1.60%
1 Month
+3.24%
YTD
+3.80%
Key Statistics
Market Cap
$187.69M
52W High
$2.05
52W Low
$1.55
P/E Ratio
17.27
50 Day MA
$1.75
200 Day MA
$1.77
Beta
0.35
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 8/5/2026 | $1.98 | $1.98 | $1.89 | $1.91 | $1.91 | 63,908 |
| 8/4/2026 | $1.81 | $1.94 | $1.81 | $1.90 | $1.90 | 45,525 |
| 7/31/2026 | $1.88 | $1.89 | $1.83 | $1.86 | $1.86 | 58,400 |
| 7/30/2026 | $1.85 | $1.90 | $1.85 | $1.88 | $1.88 | 45,661 |
| 7/29/2026 | $1.90 | $1.94 | $1.88 | $1.88 | $1.88 | 25,797 |
| 7/28/2026 | $1.88 | $1.90 | $1.86 | $1.89 | $1.89 | 51,644 |
| 7/27/2026 | $1.91 | $1.91 | $1.86 | $1.86 | $1.86 | 10,704 |
| 7/24/2026 | $1.89 | $1.91 | $1.88 | $1.90 | $1.90 | 20,377 |
| 7/23/2026 | $1.88 | $1.90 | $1.85 | $1.86 | $1.86 | 117,544 |
| 7/22/2026 | $1.81 | $1.90 | $1.81 | $1.86 | $1.86 | 55,942 |
Analyst Price Targets
Based on analyst covering LOVE
Wall Street analysts forecast LOVE stock price to rise 76.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.38
+76.7% Upside
Current Price
C$1.91
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LOVE's historical volatility
30-Day Vol
40.3%
Annualized
90-Day Vol
36.1%
Annualized
Trend (90d)
+34.4%
Annualized drift
90d Mean
C$2.16
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.99 | C$1.73 – C$2.29 |
| 60 trading days | C$2.07 | C$1.70 – C$2.52 |
| 90 trading days | C$2.16 | C$1.70 – C$2.75 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Cannara Biotech Inc.
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Financials
- Revenue (TTM)
- $117.33M
- EBITDA
- $24.73M
- Profit Margin
- 9.25%
- ROE (TTM)
- 9.68%
- EPS (Diluted)
- 0.11
- Book Value
- 1.27
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About LOVE
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
LOVE.TO news timeline
15 articles covering LOVE.TO, most recent first
LatestTop penny stocks on the TSX & TSXV — August 6, 2026
July 2026
- Why Cannara Biotech Inc. stock is gaining today
- What's Going On With Cannara Biotech Inc. Stock Wednesday?
- Why Cannara Biotech Inc. stock is sliding today
- Why Cannara Biotech Inc. stock is rising today
- What's Going On With Cannara Biotech Inc. Stock Wednesday?
- Cannara Biotech Inc. LOVE Earnings Beat Estimates by 29.7%
- Why Cannara Biotech Inc. stock is skyrocketing today
- Will Cannara Biotech Inc. (LOVE) Beat Earnings Estimates in Its Next Report?
- Why Cannara Biotech Inc. stock is sliding today
- Why Cannara Biotech Inc. stock is sliding today
- Why Cannara Biotech Inc. stock is rising today